
The Week Ahead: Hom...


| Price and Volume | |
|---|---|
| Recent Price | 13.16 |
| 52 Week High | 14.33 |
| 52 Week Low | 6.74 |
| Avg. Daily Vol. (Mil) | 0.17 |
| Beta (3 year) | 0.68 |
| Share Related Items | |
| Mkt Cap (Mil) | 395.22 |
| Shares Out (Mil) | 30.03 |
| Float (Mil) | 26.17 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 0.90 |
| Current Ratio | 2.00 |
| LT Debt/ Equity | 0.43 |
| Total Debt / Equity | 0.43 |
| Valuation Ratios | |
| Price Earnings | 6.00 |
| Price/Sales | 1.40 |
| Price/Book | 2.30 |
| Price/Cash Flow | 4.50 |
| Per Share Data | |
| Earnings | 2.19 |
| Sales | 9.37 |
| Book Value | 5.72 |
| Cash Flow | 2.93 |
| Business Summary | |
|---|---|
| Cambrex Corporation is a life sciences company that provides essential products and services to accelerate drug discovery, development and manufacturing processes for human therapeutics. | |
| General Information | |
| One Meadowlands Plaza
East Rutherford, NJ 07073 |
|
| www.cambrex.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 891 | |
| CEO: Steven M. Klosk | |
| Short Interest | |
| Current Month (Mil) | 0.47 |
| Previous Month (Mil) | 0.38 |
| Short Interest Ratio (Days) | 3.40 |
| Management Effectiveness | |
| Return on Equity | 38.70 |
| Return on Assets | 16.20 |
| Return on Investments | 27.10 |
| Profitability | |
| Gross Margin | 40.70 |
| EBIT Margin | 14.10 |
| Profit Margin | 23.60 |